Efficiency of the use of the drug phlebodia in pregnant women with increased veins of hemoroidal nodes (hemorrhoids)

Author:

Alieva R. Ya.1,Baimatova Z. K.1,Gulakova D. M.1,Murodova Sh. M.1

Affiliation:

1. State Research Institute of Obstetrics, Gynecology and Perinatology of the Ministry of Health and Social Protection of the Republic of Tajikistan; GU GMTs No. 2 named after. K.T. Tajiev

Abstract

Purpose of the study. To evaluate the results of the effectiveness of the use of the drug Phlebodia in pregnant women with hemorrhoids.Object and methods of research. We examined 37 patients who were diagnosed with acute and chronic hemorrhoids, who were in the department of pathology of pregnant women No. 1 of the State Research Institute of AH and P for the period 2000-2021. These patients were consulted by a proctologist. After the discharge of pregnant women from the pathology department, further observation was introduced by a proctologist. Inclusion criteria - the presence of subjective and objective signs of the disease in pregnant women. Treatment with Phlebodia 600 was carried out according to a certain scheme: first, 4 days, 1 tablet 3 times a day with meals, and then 1 tablet 2 times a day.Results of the study and their discussion. The leading symptom of hemorrhoids in pregnant women was pain, which occurred in 81.0%, discomfort (itching) was observed in 43.2%, bleeding from the anus in 32.4%, respectively. When prescribing the drug Flebodia, we achieved positive results. In the course of our study, it was possible in 91.8% of pregnant women with an established diagnosis of hemorrhoids to achieve such positive results as the elimination of such symptoms as the cessation of bleeding, perianal edema, pain and itching.Conclusion. In pregnant women who used the drug Flebodia 600, there was a positive hemodynamics in the clinical symptoms of hemorrhoids.

Publisher

Healthcare of Tajikistan

Reference7 articles.

1. Blagodarnyi L.A. Effektivnost' flebotropnykh preparatov. Rezul'taty metaanaliza (na osnove Kokranovskogo tsentral'nogo reestra kontroliruemykh issledovanii, Cochrane Central Register of Controlled Trials). – M., 2015. – 24 s.

2. Belik. B.M. Rol' flebotropnykh preparatov v kompleksnom lechenii ostrogo gemorroya. / B.M. Belik. A.N. Kovalev, A.P. Khatlamadzhiyan. // Koloproktologiya. – 2018. №2 (64). s. 48-53

3. Vasil'ev S.V. Sovremennye vozmozhnosti profilaktiki i lecheniya gemorroya v dorodovom i poslerodovom periode. / S.V. Vasil'ev, D.E. Popov, A.I. Nedozimovannyi i soavt. // Koloproktologiya. – 2016. - №3 (57). – s. 13-17.

4. Elokhina T.B., Tyutyunnik V.L., Balushkina A.A. Gemorroi: printsipy terapii v akusherskoi praktike. Russkii meditsinskii zhurnal. – 2010. – t. 18. – №4. – s. 200-203.

5. Shelygin Yu.A., Veselov A.V., Serbina A.A. Osnovnye napravleniya organizatsii spetsializirovannoi koloproktologicheskoi pomoshchi // Koloproktologiya. 2017. №59 (1). - s.76-86.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3